

Cover Story
In Brief


Drugs & Targets
Trending Stories
- Preparing to take care of each other in ways we never imagined
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - “The Agency finds you are not fit…”
HHS notifications of firing add insult to injury - As cancer research is threatened, we must engage in political advocacy